We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.4%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$149B
AUM Growth
+$5.43B
(+3.8%)
Cap. Flow
-$4.27B
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$151M |
| 2 |
Alibaba
BABA
|
+$115M |
| 3 |
XPeng
XPEV
|
+$79M |
| 4 |
Raymond James Financial
RJF
|
+$71.4M |
| 5 |
Allogene Therapeutics
ALLO
|
+$64.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$285M |
| 2 |
NetApp
NTAP
|
+$236M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$220M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$209M |
| 5 |
Adobe
ADBE
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.47% |
| 2 | Healthcare | 26.97% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.07T
| $7.79B | 5.24% |
33,959,267
-1,418,968
| -4% | -$285M |
|
2
Biogen
BIIB
$29.9B
| $5.7B | 3.83% |
16,458,506
-299,750
| -2% | -$90.8M |
|
3
Microsoft
MSFT
$2.84T
| $5.06B | 3.4% |
18,675,549
-742,145
| -4% | -$189M |
|
|
4
Adobe
ADBE
$89.5B
| $4.29B | 2.88% |
7,323,998
-389,235
| -5% | -$201M |
|
5
FedEx
FDX
$74.5B
| $4.12B | 2.76% |
13,794,161
-142,548
| -1% | -$42.3M |
|
6
Amgen
AMGN
$203B
| $3.96B | 2.66% |
16,249,072
-425,500
| -3% | -$105M |
|
7
Texas Instruments
TXN
$255B
| $3.79B | 2.55% |
19,703,319
-879,834
| -4% | -$165M |
|
8
Micron Technology
MU
$1.04T
| $3.71B | 2.49% |
43,652,263
-1,776,326
| -4% | -$150M |
|
|
9
Alibaba
BABA
$269B
| $3.55B | 2.38% |
15,635,272
+518,556
| +3% | +$115M |
|
|
10
Alphabet (Google) Class A
GOOGL
$3.91T
| $3.17B | 2.13% |
25,975,980
-1,881,180
| -7% | -$220M |
|
11
Southwest Airlines
LUV
$22.1B
| $3B | 2.02% |
56,511,976
-2,464,294
| -4% | -$148M |
|
12
AstraZeneca
AZN
$263B
| $2.92B | 1.96% |
24,352,097
-604,516
| -2% | -$66.3M |
|
13
Tesla
TSLA
$1.24T
| $2.76B | 1.85% |
12,184,395
-216,645
| -2% | -$47M |
|
14
Sony
SONY
$123B
| $2.74B | 1.84% |
140,956,025
-2,881,320
| -2% | -$58.4M |
|
15
KLA
KLAC
$275B
| $2.63B | 1.77% |
81,059,840
-3,332,250
| -4% | -$107M |
|
16
Wells Fargo
WFC
$261B
| $2.26B | 1.52% |
49,869,195
+153,935
| +0.3% | +$6.87M |
|
17
Thermo Fisher Scientific
TMO
$211B
| $2.21B | 1.48% |
4,377,264
-109,910
| -2% | -$51.9M |
|
|
SCHW
18
Charles Schwab
SCHW
$177B
| $2.12B | 1.43% |
29,171,839
-240,440
| -0.8% | -$17M |
|
|
19
Alphabet (Google) Class C
GOOG
$3.9T
| $2.12B | 1.42% |
16,895,400
-1,750,780
| -9% | -$209M |
|
20
JPMorgan Chase
JPM
$939B
| $1.99B | 1.34% |
12,787,174
-660,781
| -5% | -$104M |
|
21
Intel
INTC
$466B
| $1.96B | 1.32% |
34,918,555
+709,880
| +2% | +$41.7M |
|
22
Baidu
BIDU
$35.8B
| $1.94B | 1.3% |
9,495,285
+60,406
| +0.6% | +$12.1M |
|
|
23
NetApp
NTAP
$32.9B
| $1.87B | 1.26% |
22,884,731
-3,016,791
| -12% | -$236M |
|
24
Novartis
NVS
$295B
| $1.76B | 1.18% |
19,281,850
-1,261,950
| -6% | -$112M |
|
25
Boston Scientific
BSX
$65.8B
| $1.71B | 1.15% |
40,020,445
-991,895
| -2% | -$41.7M |
|
Similar funds
Primecap Management's Q2 2021 Portfolio in Review
As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
- Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
- Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
- Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
- Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
- Primecap Management opened 11 new positions and closed 5 in Q2 2021.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.
Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.